EN
Patient-first cell therapy innovation
 
Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
  • 0
Zhao L., He R., Long H., Guo B., Jia Q., Qin D., Liu S.-Q., Wang Z., Xiang T.,  Zhang J., Tan Y., Huang J., Chen J., Wang F., Xiao M., Gao J., Yang X., Zeng H., Wang X., Hu C., Alexander P. B., Symonds A.L.J.,  Yu J., Wan Y., Li Q.-J.*, Ye L.*, Zhu B.* (2018) Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells. Nature Medicine 24(10):1536-1544 (*: Corresponding authors, PMCID: PMC6211844)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211844/



Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Products and Clinic
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer